In the large cohort of unselected gastric cancer patients retrieved from the Kaplan-Meier Plotter database ( https://www.kmplot.com/analysis/ ), we found a highly significant correlation between elevated NAT10 expression and poorer progression-free survival (PFS) (Sup.
← all excerpts
NAT10 promotes cisplatin resistance and immune escape by increasing the expression of DUSP1 and PD-L1 in gastric cancer.
1
—
—